102000-86-2Relevant articles and documents
Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs)
Szabó, Gy?rgy,Kolok, Sándor,Orgován, Zoltán,Vastag, Mónika,Béni, Zoltán,Kóti, János,Sághy, Katalin,Lévay, Gy?rgy I.,Greiner, István,Keser?, Gy?rgy M.
, (2019/12/30)
A scaffold hopping strategy converted the known 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidine core (1 and 2) by cyclization to a fused [6 + 5+6] membered heterocyclic mGluR2 PAM scaffold. Pharmacophore guided structure?activity relationship (SAR) studies resulted in a series of potent and metabolically stable mGluR2 PAMs. A representative optimized compound (95) having the most balanced profile, demonstrated efficacy in the PCP-induced hyper-locomotion model in mice that revealed the new chemotype being a promising PAM lead targeting mGluR2 receptors and providing support for further translational studies.
